Innovative AI Companion to Support Breast Cancer Patients Developed by Samueli Institute and XOLTAR

Full Article
Innovative AI Companion to Support Breast Cancer Patients Developed by Samueli Institute and XOLTAR

A groundbreaking AI companion has been developed through a collaboration between the Samueli Integrative Cancer Pioneering Institute and XOLTAR. This innovative application aims to support breast cancer patients by allowing them to video chat with an AI-based virtual companion 24/7, report symptoms, and receive guidance on managing side effects. The project, named EngageX, seeks to enhance patient care and improve treatment outcomes by facilitating real-time communication between patients and their medical teams.

The AI companion will provide personalized responses based on the patient's reported symptoms, helping them navigate side effects from their treatments. By collecting data on patient experiences, the application will not only assist individual patients but also contribute to broader improvements in oncological care. This initiative represents a significant step forward in integrating AI technology into healthcare, aiming to transform the patient experience and enhance quality of life.

• AI companion enables 24/7 support for breast cancer patients.

• EngageX project aims to improve treatment outcomes through real-time patient data.

Key AI Terms Mentioned in this Article

AI Companion

The AI companion in this project helps breast cancer patients manage their treatment side effects through continuous communication.

Real-time Communication

This feature allows patients to receive immediate responses to their health inquiries, enhancing their treatment experience.

Data Collection

In this context, data collected from patient interactions will be used to improve overall treatment protocols.

Companies Mentioned in this Article

Samueli Institute

The Samueli Institute is leading the development of the AI companion to enhance patient care in oncology.

XOLTAR

XOLTAR is responsible for creating the AI companion that will support breast cancer patients during their treatment journey.

Get Email Alerts for AI News

By creating an email alert, you agree to AIleap's Terms of Service and Privacy Policy. You can pause or unsubscribe from email alerts at any time.

Latest Articles

Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive
TechCrunch 6month

Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600

AI In Education - Up-level Your Teaching With AI By Cloning Yourself
Forbes 6month

How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.

Trump's Third Term - How AI Can Help To Overthrow The US Government
Forbes 6month

Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.

Sam Altman Says OpenAI Will Release an 'Open Weight' AI Model This Summer
Wired 6month

Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.

Popular Topics